Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 5 years ago

Possible Interaction: Resveratrol and Ng-Nitroarginine Methyl Ester

Research Papers that Mention the Interaction

“The potentiating effect of RVT was significantly inhibited by L-NG-nitroarginine methyl ester (L-NAME, 10−4 M, for 30 min) incubation in both groups.”
Aging Clinical and Experimental Research  •  2016  |  View Paper
“Using the model of endothelial dysfunction in rats induced by L-NAME it was shown, that RES markedly attenuated the inhibition effect of L-NAME on NO synthesis.”
Biomeditsinskaia khimiia  •  2015  |  View Paper
“Treatment of the arterial rings with the eNOS inhibitor L-NAME , but not with indomethecin or endothelium denudation, obviously affected the relaxant effects of resveratrol.”
Nan fang yi ke da xue xue bao = Journal of Southern Medical University  •  2015  |  View Paper
“The … of resveratrol on 125I-MCP-1 binding to THP-1 cells and on … expression determined by FACS analysis was attenuated by treatment with L-NAME (NOS inhibitor), PD98059 (MAPK inhibitor) and LY294002 (PI3K inhibitor), whereas neither X/… oxygen species generator) nor ICI182780 (estrogen receptor antagonist) had any effect.”
Atherosclerosis  •  2007  |  View Paper
“In the presence of the endothelium, … soluble guanylate cyclase inhibitor), Nω-nitro-l-arginine methyl ester (L-NAME, nitric oxide synthase inhibitor), tetraethylammonium (TEA, nonselective calcium activator potassium channel blocker), 4-aminopyridine (… propranolol (β-adrenergic receptor blocker) led to a significant reduction in the vasorelaxation effect induced by resveratrol.”
Inflammopharmacology  •  2020  |  View Paper
“All the effects of Res demonstrated were inhibited by L-NAME (a nitric oxide (NO) synthase inhibitor) and MB [a cyclic guanosine monophosphate (cGMP) inhibitor].”
Molecular medicine reports  •  2014  |  View Paper
“… N-nitro-L-arginine methyl ester (L-NAME, 10−4 M) or soluble guanylate cyclase inhibitor 1H-[1,2,4]…-1-one (ODQ, 10−5 M) caused a significant inhibition on relaxation response to RVT , whereas cyclooxygenase inhibitor indomethacin (10−5 M) … responses of corpus cavernosum strips to RVT.”
International Journal of Impotence Research  •  2013  |  View Paper
“Treatment with L-NAME (a nitric oxide synthase inhibitor), glibenclamide and tetraethylammonium (TEA) significantly attenuated the vasorelaxing effect of Res.”
Vascular pharmacology  •  2013  |  View Paper
“And the effect of Res was blocked completely by either L-NAME (an eNOS inhibitor) or MB (a cGMP inhibitor), and partly by either DS (a PKC inhibitor) or Glybenclamide (a KATP inhibitor).”
PloS one  •  2012  |  View Paper
“Cotreatment with l-NAME significantly attenuated the antirestenotic properties of Resv.”
American journal of physiology. Heart and circulatory physiology  •  2010  |  View Paper
Show More